Translate this website into the following languages:

Close Tab
UC San Diego Health
menu iconMenu
search iconSearch

Clinical Drug Trials for Alzheimer's Disease

Couple photo 

Imagine A World Without Alzheimer's Disease

UC San Diego Health is a worldwide leader in therapeutic research and state-of-the-art patient care for Alzheimer's disease. Our team is committed to translating discoveries into new treatment options. We regularly conduct clinical trials to evaluate the effectiveness of new, promising treatments.

Alzheimer's Clinical Trials: What to Expect

You do not need to be a patient at UC San Diego in order to participate in our clinical trials.

Other things to note:

  1. It does not cost anything to participate.
  2. Clinical trial length can range from six months to two years.
  3. Treatments being studied may include nasal inhalant, infusions, pills, and medical foods.
  4. Clinical trials are conducted under the supervision of a UC San Diego neurologist.
  5. Enrollment in each trial is limited.
  6. You may halt your participation at any time for any reason.

Clinical Trials Currently Underway

At any time, as many as six to ten clinical trials may be underway at UC San Diego that you may qualify for.

Those who meet the following criteria may be eligible:

  • Ages 55-90
  • Have prodromal Alzheimer's disease, mild cognitive impairment, or mild to moderate Alzheimer's disease
  • Have a study partner

To learn more, please call 858-246-1300.

Appointments & Referrals

Clinical Trials Office Location

Memory Matters

More investigational drugs are being studied now than ever. Help us beat Alzheimer's disease – volunteer for a clinical trial today.

Discoveries Magazine: "Recalling Forward"

UC San Diego scientists are working tirelessly to take the mystery out of Alzheimer's disease. Find out why we're considered the international hub of AD research. Learn more.

Illustration of a brain.
Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: